Celcuity got its cancer drug approved. Then its stock dippednews2026-07-17T18:03:35+00:00July 17th, 2026|Endpoints News|
GSK plans large study to see if shingles vaccine can prevent dementianews2026-07-17T14:52:02+00:00July 17th, 2026|Endpoints News|
GSK plans large study to see if shingles vaccine can prevent dementianews2026-07-17T14:52:02+00:00July 17th, 2026|Endpoints News|
Dimerix buys a kidney injury drug; Arpeggio appears to be winding downnews2026-07-17T14:41:37+00:00July 17th, 2026|Endpoints News|
Dimerix buys a kidney injury drug; Arpeggio appears to be winding downnews2026-07-17T14:41:37+00:00July 17th, 2026|Endpoints News|
Updated: BlossomHill and Latigo join flourishing IPO queue with cancer, pain drugsnews2026-07-17T13:54:42+00:00July 17th, 2026|Endpoints News|
Updated: BlossomHill and Latigo join flourishing IPO queue with cancer, pain drugsnews2026-07-17T13:54:42+00:00July 17th, 2026|Endpoints News|
GSK drops Phase 3 chronic cough drug in a blow to $2B Bellus Health buyoutnews2026-07-17T11:05:17+00:00July 17th, 2026|Endpoints News|
Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hirenews2026-07-17T11:00:13+00:00July 17th, 2026|Endpoints News|
Mirador unveils part of pipeline with drug from Kira to rival Tavneosnews2026-07-16T21:47:22+00:00July 16th, 2026|Endpoints News|
